Dose-ranging Study of SKF7™ for Obesity

NCT04557267 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: low-dose
DRUG: Middle-dose
DRUG: Higher-dose
DRUG: Placebo

Sponsor

Indonesia University

Collaborators

[object Object]